Skip to content

Our Purpose

Share this page:

My hope is that this model will be something other people will want to incorporate into their companies. I’d like to think that business-people will just pick a calling and use this model to help people less fortunate than themselves.
Scott Boyer OWP Pharmaceuticals
Scott Boyer
Founder and President

One World. One Standard.®

Our heartfelt and strategic purpose is to promote a future where the best treatments for neurological disorders are available to all people, at all times, in all the world. Solving a problem of this magnitude does not happen overnight. It requires intentional discipline, systematic efforts and the kind of vision that drives our team at OWP Pharmaceuticals. Our vision comes to life through our business model and never-ending dedication.

OWP Pharmaceuticals enjoys an innovative relationship with ROW Global through its hybrid business model. Together they form a concerted organization with shared goals and values that result in a true Pharmaceutical Social Enterprise. OWP uses commercial success for the common good by supporting humanitarian projects rather than solely maximizing profits.

Our focus is to support providers and patients in the US with beneficial medications. We then use profits to improve the education, diagnosis and treatment available for those living with neurological disorders in under-resourced areas of the world by donating to ROW Global.

This relationship enables us to better serve the entire community of people living with these disorders. One World. One Standard!

Patient prescription months

0

Through our strategic partnership with ROW Global, a large portion of OWP profits goes to provide resources for those living with neurological disorders in under-resourced areas of the world.

ROW has sponsored dozens of programs around the world. Part of that work has included granting more than 140,000 patient prescription months of anti-seizure medication for people who would otherwise go without.

Through our strategic partnership with ROW Global, a generous portion of OWP profits goes to provide resources for those living with neurological disorders in under-resourced areas of the world.

Patient prescription months

0

ROW has sponsored dozens of programs around the world. Part of that work has included granting more than 140,000 patient prescription months of anti-seizure medication for people who would otherwise go without.